Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.
Shevrin
D H
DH
Evanston Hospital, Division of Medical Oncology, IL 60201, USA.
Kilton
L J
LJ
Lad
T E
TE
Mullane
M
M
Esparaz
B
B
Knop
R
R
Egner
J
J
Johnson
P
P
Blough
R
R
French
S
S
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use*
D013866:Thioguanine